How to buy Amedisys stock

Amedisys, Inc is a medical care facilities business based in the US. Amedisys shares (AMED) are listed on the NASDAQ and all prices are listed in US Dollars. Amedisys employs 21,000 staff and has a trailing 12-month revenue of around USD$2 billion.

How to buy shares in Amedisys

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Amedisys. Find the stock by name or ticker symbol: AMED. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amedisys reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Amedisys, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Amedisys. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Amedisys share price

Use our graph to track the performance of AMED stocks over time.

Amedisys shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$132.9495 - USD$325.12
50-day moving average	USD$297.8444
200-day moving average	USD$260.848
Wall St. target price	USD$320.54
PE ratio	56.1438
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$4.992

Buy Amedisys shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Amedisys stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Amedisys, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amedisys financials

Revenue TTM	USD$2 billion
Operating margin TTM	10.12%
Gross profit TTM	USD$805.3 million
Return on assets TTM	9.08%
Return on equity TTM	24.62%
Profit margin	8.22%
Book value	$23.053
Market capitalisation	USD$9.2 billion

TTM: trailing 12 months

Shorting Amedisys shares

There are currently 397,879 Amedisys shares held short by investors – that's known as Amedisys's "short interest". This figure is 12.9% down from 456,769 last month.

There are a few different ways that this level of interest in shorting Amedisys shares can be evaluated.

Amedisys's "short interest ratio" (SIR)

Amedisys's "short interest ratio" (SIR) is the quantity of Amedisys shares currently shorted divided by the average quantity of Amedisys shares traded daily (recently around 180035.74660633). Amedisys's SIR currently stands at 2.21. In other words for every 100,000 Amedisys shares traded daily on the market, roughly 2210 shares are currently held short.

However Amedisys's short interest can also be evaluated against the total number of Amedisys shares, or, against the total number of tradable Amedisys shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amedisys's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Amedisys shares in existence, roughly 10 shares are currently held short) or 0.0141% of the tradable shares (for every 100,000 tradable Amedisys shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amedisys.

Find out more about how you can short Amedisys stock.

Have Amedisys's shares ever split?

Amedisys's shares were split on a 4:3 basis on 5 December 2006. So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Amedisys shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Amedisys shares which in turn could have impacted Amedisys's share price.

Amedisys share price volatility

Over the last 12 months, Amedisys's shares have ranged in value from as little as $132.9495 up to $325.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amedisys's is 0.7284. This would suggest that Amedisys's shares are less volatile than average (for this exchange).

Amedisys overview

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Frequently asked questions

• What percentage of Amedisys is owned by insiders or institutions?

  Currently 3.359% of Amedisys shares are held by insiders and 90.624% by institutions.

• How many people work for Amedisys?

  Latest data suggests 21,000 work at Amedisys.

• When does the fiscal year end for Amedisys?

  Amedisys's fiscal year ends in December.

• Where is Amedisys based?

  Amedisys's address is: 3854 American Way, Baton Rouge, LA, United States, 70816

• What is Amedisys's ISIN number?

  Amedisys's international securities identification number is: US0234361089

• What is Amedisys's CUSIP number?

  Amedisys's Committee on Uniform Securities Identification Procedures number is: 023436108